Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ORGAN PROCUREMENT AND TRANSPLANTATION—M.D. Fla.: CMS organ procurement ranking rule survives APA challenge
    • AUDITS AND MONITORING—OIG REPORTS: Tennessee Medicaid claimed $59.3 million in improper Medicaid reimbursement for targeted case management services
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—NOTICES: DEA denies cannabis manufacturer registration bid over compliance gaps
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COSMETICS—N.D. Cal.: Lip balm false labeling suit moves forward
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—NOTICES: FDA clears path for generic ISTURISA approvals
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA establishes Class II controls for vascular autograft storage solutions
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—OIG REPORTS: CMS policy on Part B drug price-substitutions saved Medicare and enrollees $1.6 million in 2024
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • QUALITY OF CARE—D.D.C.: Jurisdictional nuances lead to stalemate on dispositive motions about HHS NPDB malpractice report decision
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • SENATE NEWS—Bipartisan Bill to Update HIPAA Cyber Rules Clears Senate
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, PRESCRIPTION DRUGS—OIG REPORTS: CMS policy on Part B drug price-substitutions saved Medicare and enrollees $1.6 million in 2024, (Oct 2, 2026)

    By K. C. Salcedo

    Since 2013, CMS substituted payment amounts based on sales prices with amounts based on manufacturer prices when sales prices exceeded manufacturer prices by 5 percent, resulting in $7.8 million in savings to Medicare and enrollees, including $1.6 mi ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use